Follow the people · Insider
Michael Charles Ferguson Hannay
Michael Charles Ferguson Hannay files insider transactions with the SEC as a chief prod & supply chain off of Bicycle Therapeutics (BCYC). We hold 6 disclosed purchases and sales filed since 21 March 2024, 2 of them in the last 90 days.
- Files forBCYC
- Disclosed buys and sells6 in all, 2 in the last 90 days
- Last disclosure7 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 19 March 2024 — 15 July 2026Chief Prod & Supply Chain Off · Bicycle Therapeutics (BCYC)27 Form 4 lines · source: SEC Form 4
Everything they disclosed
27 entries, newest first — one per disclosure report, one per Form 4 line- was granted 60,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 417 July 2026Employee Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 1,506 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 255 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 6 July 2026 · filed 7 July 2026
- ▼ sold on the open market 1,521 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 2 April 2026 · filed 6 April 2026
- ▼ sold on the open market 251 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 6 April 2026 · filed 6 April 2026
- was granted 50,000 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 2,827 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 2,367 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- was granted 100,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 100,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 50,000 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 2,827 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 2,367 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- ▼ sold on the open market 473 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 2 October 2025 · filed 6 October 2025
- ▼ sold on the open market 250 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 3 October 2025 · filed 6 October 2025
- ▼ sold on the open market 474 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 2 July 2025 · filed 7 July 2025
- ▼ sold on the open market 248 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 3 July 2025 · filed 7 July 2025
- ▼ sold on the open market 467 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 266 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 3 April 2025 · filed 4 April 2025
- was granted 87,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2025Employee Stock Option (right to buy) · traded 2 January 2025 · filed 6 January 2025
- was granted 35,000 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 1,879 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 239 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 3 January 2025 · filed 6 January 2025
- ▼ sold on the open market 247 shares of Bicycle TherapeuticsSEC Form 44 October 2024Ordinary Shares · traded 3 October 2024 · filed 4 October 2024
- ▼ sold on the open market 246 shares of Bicycle TherapeuticsSEC Form 48 July 2024Ordinary Shares · traded 3 July 2024 · filed 8 July 2024
- ▼ sold on the open market 257 shares of Bicycle TherapeuticsSEC Form 412 April 2024Ordinary Shares · traded 11 April 2024 · filed 12 April 2024
- was granted 58,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 421 March 2024Employee Stock Option (right to buy) · traded 19 March 2024 · filed 21 March 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.